RIO DE JANEIRO, BRAZIL - The Ministry of Health reported that the number of doses against Covid-19 offered by Pfizer pharmaceuticals to Brazil would be insufficient to meet the country's demand. The initial provision by the laboratory, according to the portfolio, comprises two first batches of 500,000 doses and a third batch of one million doses, totaling two million doses.
"For Brazil, it would frustrate all Brazilians, because with few doses we would have to choose who would be administered the vaccine, in a country with over 212 million inhabitants," the Ministry said in a note. The Brazilian . . .